| Registry | NCT07721064 |
|---|---|
| Status | Not yet recruiting |
| Phase | Not applicable |
| Study type | Interventional; randomized, factorial, masking: single, treatment |
| Enrollment | 747 (Estimated) |
| Sponsor | University of Virginia (Other); collaborators: National Cancer Institute (NCI) |
| Conditions | Insomnia, Depression |
| Interventions | Digital Insomnia Program, Digital Mental Health Program, Psychoeducation (Behavioral) |
| Dates | start 2026-09-30 (estimated), primary completion 2029-08-01 (estimated), completion 2029-08-30 (estimated), first posted 2026-07-22, last updated 2026-07-24 |
| Locations | 1 site in United States |
Related Papers Related Patents Related Grants Related Experts
All trials for Insomnia All trials for Depression All trials of Digital Insomnia Program All trials of Digital Mental Health Program
Co-occurring symptoms of insomnia and depression is very common in breast cancer survivors, and it is critical that scalable and easily accessible digital behavioral interventions are made available. Digital health interventions are scalable and accessible. Moreover, behavioral digital interventions have been shown to be effective in reducing symptoms of insomnia and depression, respectively, in breast cancer survivors, suggesting strong potential for public impact, though their potential for addressing co-occurring symptoms of insomnia/depression has not been tested. The purpose of this study is to evaluate the efficacy of a digital insomnia program and a digital mental health program in multiple ways: 1) as standalone interventions to reduce both symptoms of co-occurring insomnia and depression for breast cancer survivors; and 2) as components in adaptive behavioral treatment strategies that optimally sequence them for survivors who need additional support, resulting in a multifaceted supportive approach that is low cost, easily accessible, and highly efficient.
| Arm | Type | Interventions | Description |
|---|---|---|---|
| Digital Insomnia Program First | Experimental | Behavioral: Digital Insomnia Program; Behavioral: Digital Mental Health Program | Participants assigned to receive the digital insomnia program first will use it for 9 weeks. Based on their response after 9 weeks, some will be re-randomized to receive an additional intervention (digital mental health program) or not. |
| Digital Mental Health Program First | Experimental | Behavioral: Digital Insomnia Program; Behavioral: Digital Mental Health Program | Participants assigned to receive the digital mental health program first will use it for 9 weeks. Based on their response after 9 weeks, some will be re-randomized to receive an additional intervention (digital insomnia program) or not. |
| Psychoeducation Only | Active comparator | Behavioral: Psychoeducation | Participants assigned to this arm will only receive the psychoeducation program for 9 weeks. They will not be eligible to be re-randomized to receive additional program. |
Sex: Female, ages: 18 Years to any
Inclusion Criteria: * (1) age ≥18 years * (2) Diagnosed with stage 0-3 breast cancer * (3) Primary treatment for cancer (i.e., chemotherapy, immunotherapy, radiation, and surgical procedures intended to remove malignant tissue) finished between 3 months to 5 years from enrollment, with the exception of adjuvant hormonal, endocrine, and immunotherapy * (4) elevated insomnia severity as measured by the Insomnia Severity Index (ISI) score ≥ 10, and elevated symptoms of depression as measured by the Patient Health Questionnaire-8 (PHQ-8) score ≥ 10 * (5) meets DSM 5 criteria for insomnia and depression. Exclusion Criteria: * (1) Current behavioral or psychological treatment for insomnia or depression * (2) a change in medication for insomnia or depression within the past 4 weeks * (3) irregular sleep schedules or shift work (i.e., usual bedtimes outside 8:00 p.m.-2:00 a.m. or arising time outside 4:00 a.m.-10:00 a.m.) * (4) mental health condition deemed to interfere with study procedures or put the participant at undue risk based on self-reported history of psychosis or bipolar disorder, or active suicidal ideation that necessitates more intense care (as indicated from the Pitt-Optimum Suicide Management Protocol) * (5) other self-reported untreated sleep disorders (i.e., obstructive sleep apnea, restless legs syndrome) * (6) no reliable internet access (e.g., home broadband, public network, personal data plan) by smartphone * (7) cannot read and speak English * (8) does not reside within the US.
| Facility | City | Country | Status |
|---|---|---|---|
| University of Virginia | Charlottesville, Virginia | United States |
NIH grants: R01CA295673